THE NEWSROOM

Search
Categories
Archives

Investment Monitoring From Robbins LLP

To ensure your financial investments are being managed honestly, enroll in Stock Watch, our free investment monitoring service for individual and institutional investors.

Investigation of Nektar Therapeutics

Are you a former employee of Nektar Therapeutics (NKTR) and own stock in the company? Robbins LLP is investigating breaches of fiduciary duty by the officers and board of directors

Read More

Investigation of Splunk Inc.

Splunk, Inc. (SPLK) Misled Shareholders About its Third Quarter 2021 Financial Results     On October 21, 2020, Splunk held a call with several analysis at the Virtual Analyst & investor

Read More

Investigation of Fortress Biotech, Inc.

Fortress Biotech, Inc. (FBIO) Misled Shareholders About the Viability of its Intravenous Tramadol Product    In December 2019, Fortress Biotech’s wholly owned subsidiary, Avenue Therapeutics, Inc., submitted a New Drug

Read More
Background of Stock market graph chart
Robbins LLP News

Nasdaq – Diverse Board Members

Nasdaq Acknowledges Value of Diverse Board On December 1, 2020, Nasdaq asked the U.S. Securities and Exchange Commission for permission to require that all companies listed on its U.S. stock

Read More

Investigation of Fortress Biotech, Inc.

Fortress Biotech, Inc. (FBIO) Misled Shareholders About the Viability of its Intravenous Tramadol Product    In December 2019, Fortress Biotech’s wholly owned subsidiary, Avenue Therapeutics, Inc., submitted a New Drug

Read More
Skip to content